WuXi XDC and Celltrion, Inc. announced that they have signed a Memorandum of Understanding (MOU) for comprehensive and integrated services which refer to the development, and manufacturing of bioconjugates include antibody-drug conjugates (ADCs). Under the collaboration, Celltrion will delegate WuXi XDC as primary service provider on each of the integrated projects, from process development to GMP manufacturing, within the global territory. WuXi XDC will be strategic service partner to support Celltrion's innovative pipeline advances, providing comprehensive services from process development to one-stop GMP manufacturing, aiming to accelerate the development of ADCs at a fast speed and with high quality.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.5 USD | +2.50% | +18.09% | -35.94% |
Mar. 25 | WuXi XDC Cayman Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | WuXi Shares Fall as Washington Lobbying Group Cuts Ties | DJ |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
176,600 KRW | -0.45% | +2.14% | 26.59B | ||
20.5 USD | +2.50% | +18.09% | 3.09B | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.94% | 3.09B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 2268 Stock
- News WuXi XDC Cayman Inc.
- WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates